Testing effectiveness (Phase 2)UnknownNCT01802450What this trial is testingDasatinib in Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Myeloid Leukemia PETHEMA Foundation 18
Early research (Phase 1)Study completedNCT01756118What this trial is testingA Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Myelocytic, AcuteChronic Myelogenous Leukemia With Crisis of Blast Cells Goethe University 24
Testing effectiveness (Phase 2)Study completedNCT00769327What this trial is testingNilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Early research (Phase 1)Study completedNCT00098423What this trial is testingTanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00346359What this trial is testingFludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more Fred Hutchinson Cancer Center 40
Not applicableUnknownNCT05543161What this trial is testing"Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"Who this might be right forChronic Myeloid Leukemia, Chronic Phase Sohag University 50
Not applicableStudy completedNCT02487069What this trial is testingAllo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyWho this might be right forAcute LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome Nanfang Hospital, Southern Medical University 876
Large-scale testing (Phase 3)Ended earlyNCT03547154What this trial is testingPolyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)Who this might be right forChronic Myelogenous Leukemia Merck Sharp & Dohme LLC 344
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Early research (Phase 1)WithdrawnNCT05456269What this trial is testingBisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDSWho this might be right forAcute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more Racura Oncology Ltd
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144
Early research (Phase 1)Study completedNCT00038051What this trial is testingEvaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloproliferative Disorders+1 more M.D. Anderson Cancer Center 28
Early research (Phase 1)Ended earlyNCT01159301What this trial is testingEntinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT04372433What this trial is testingIO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMMLWho this might be right forAML With Monocytic DifferentiationCMML Immune-Onc Therapeutics 67
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Post-approval studies (Phase 4)Study completedNCT02546674What this trial is testingStudy Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 171
Testing effectiveness (Phase 2)Study completedNCT00796068What this trial is testingTreosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more Fred Hutchinson Cancer Center 130
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654768What this trial is testingTesting the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid LeukemiaWho this might be right forChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive SWOG Cancer Research Network 81